The Tallwood Canine Cancer Research Initiative.
At The Jackson Laboratory (JAX), we are committed to searching for cures for human disease, and we’ve asked some unusual partners to help us: man’s best friend! By researching canines, we not only help humans, but dogs too.
The Tallwood Canine Cancer Research Initiative at JAX is the first of its kind: it will create a biobank of fully sequenced dog tumors that scientists around the world can use in their cancer research. Human and canine cancers are very similar, and our goal is to use insights we learn about the mechanism of canine cancer genetics to help develop future predictors and treatments for humans and dogs too.
This major research initiative was made possible with a $500,000 gift by an anonymous donor from Connecticut.
JAX is working with veterinarians across the country to collect tumor samples from canine cancer patients whose owners volunteer to participate in the program. Comparing cancerous mutations in dogs of the same breed and across mixed breeds is expected to yield crucial information in better understanding cancer’s roots and aid the development of future treatments. The program was launched with the help of Patrick, a happy and healthy Irish wolfhound whose blood sample was the very first one used in genome sequencing for comparison to cancer genomes of sick dogs.
Will you help us find cures for human and canine cancers?
Get more information
For general inquiries about our research and how to participate in the program, please contact us at tccri@jax.org.
A $500,000 gift by an anonymous donor from Connecticut has helped JAX launch the Tallwood Cancer Canine Research Initiative, which is focused on finding cures for human and canine cancers.
Charles Lee, scientific director of JAX Genomic Medicine, tells the Hartford Courant that he is optimistic we will discover new and innovative ways to treat many types of cancer in both humans and dogs.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.